Showing 1 - 10 of 43
To help inform a conference organised by the Germany Ministry of Health (BMG) and the OECD on ‘Managing Hospital Volumes’ on the 11th April 2013, the OECD Secretariat produced this paper giving an international perspective on Germany’s situation and the current policy debate. It provides a...
Persistent link: https://www.econbiz.de/10011007207
Major disparities in the cost of health care have made the pricing of specialist and hospital services a contentious issue in South Africa, particularly in the private sector. To help inform policy debate, this paper profiles selected experiences on the pricing of health services, competition...
Persistent link: https://www.econbiz.de/10011007214
Health workforce planning aims to achieve a proper balance between the supply and demand for different categories of health workers, in both the short and longer-term. Workforce planning in the health sector is particularly important, given the time and cost involved in training new doctors and...
Persistent link: https://www.econbiz.de/10011007219
<OL><LI>While France has a universal public health insurance system, the coverage it provides is incomplete and the vast majority the French population has private complementary health insurance. Among OECD countries, the share of health care financed by private insurance is third highest behind the US...</li></ol>
Persistent link: https://www.econbiz.de/10005049183
This paper describes and assesses pharmaceutical pricing and reimbursement policies in Canada, considering them in the context of the broader policy and market environment in which they operate, and investigating their role in contributing to Canada’s achievements in meeting a range of...
Persistent link: https://www.econbiz.de/10005049185
and reimbursement scheme in 2002. Its main features are the use of cost-effectiveness analysis for determining the … reimbursement status of new pharmaceuticals and mandatory substitution of the lowest-cost generic alternative. The use of cost-effectiveness …
Persistent link: https://www.econbiz.de/10005049187
<OL><LI>This study updates and extends a previous study on equity in physician utilisation for a subset of the countries analyzed here (Van Doorslaer, Koolman and Puffer, 2002). It updates results to 2000 for 13 countries and adds new results for eight countries: Australia, Finland, France, Hungary,...</li></ol>
Persistent link: https://www.econbiz.de/10005049188
expenditure. The effectiveness of international price referencing in limiting Slovak prices for on-patent pharmaceutical products … social insurance scheme, the cost-effectiveness of new pharmaceuticals is not assessed. On the other hand, certain policy …
Persistent link: https://www.econbiz.de/10005049192
<OL><LI>This paper analyses the Slovak health insurance system and the policy challenges it faces. It describes the structure of health coverage and health sector reforms being implemented by the Slovak government. It provides a preliminary assessment of the possible impact of such reforms, with a focus...</li></ol>
Persistent link: https://www.econbiz.de/10005049195
<OL><LI>Private health insurance (PHI) is the sole source of primary health coverage for a third of the Netherlands’ population earning above a set income threshold. Social insurance (together with limited public (tax-based financing) is the main source of health coverage for the majority of the...</li></ol>
Persistent link: https://www.econbiz.de/10005049196